Nanjing Vazyme Biotech Co Ltd
688105
Company Profile
Business description
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
Contact
Kechuang Road
Floor 1-6, East Section, Building C1-2
Hongfeng Science and Technology Park, Jiangsu
Economic and Technological Development Zone
Nanjing210000
CHNT: +86 2585771179
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
3,002
Stocks News & Analysis
stocks
ASX share undervalued as margins expected to rebound
This ASX share remains overlooked despite a strong outlook.
stocks
Cheap retail REIT with an attractive yield
Lower consumer spending unlikely to buckle this retail REIT.
stocks
Expanding store network for ASX listed retailer
Sales growth but lack of margin expansion due to competition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,184.50 | 68.80 | 0.75% |
| CAC 40 | 8,447.27 | 63.26 | 0.75% |
| DAX 40 | 24,910.41 | 16.40 | 0.07% |
| Dow JONES (US) | 51,999.67 | 328.64 | 0.64% |
| FTSE 100 | 10,494.21 | 63.59 | 0.61% |
| HKSE | 24,497.54 | 3.59 | 0.01% |
| NASDAQ | 26,376.34 | 307.60 | -1.15% |
| Nikkei 225 | 69,733.14 | 328.64 | 0.47% |
| NZX 50 Index | 13,402.24 | 23.89 | -0.18% |
| S&P 500 | 7,511.35 | 42.94 | -0.57% |
| S&P/ASX 200 | 8,967.00 | 66.20 | 0.74% |
| SSE Composite Index | 4,089.26 | 2.63 | -0.06% |